Literature DB >> 21212348

Innate or adaptive immunity? The example of natural killer cells.

Eric Vivier1, David H Raulet, Alessandro Moretta, Michael A Caligiuri, Laurence Zitvogel, Lewis L Lanier, Wayne M Yokoyama, Sophie Ugolini.   

Abstract

Natural killer (NK) cells were originally defined as effector lymphocytes of innate immunity endowed with constitutive cytolytic functions. More recently, a more nuanced view of NK cells has emerged. NK cells are now recognized to express a repertoire of activating and inhibitory receptors that is calibrated to ensure self-tolerance while allowing efficacy against assaults such as viral infection and tumor development. Moreover, NK cells do not react in an invariant manner but rather adapt to their environment. Finally, recent studies have unveiled that NK cells can also mount a form of antigen-specific immunologic memory. NK cells thus exert sophisticated biological functions that are attributes of both innate and adaptive immunity, blurring the functional borders between these two arms of the immune response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212348      PMCID: PMC3089969          DOI: 10.1126/science.1198687

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  78 in total

Review 1.  Self-tolerance of natural killer cells.

Authors:  David H Raulet; Russell E Vance
Journal:  Nat Rev Immunol       Date:  2006-07       Impact factor: 53.106

2.  T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

Authors:  Jacqueline G O'Leary; Mahmoud Goodarzi; Danielle L Drayton; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2006-04-16       Impact factor: 25.606

Review 3.  KIR and disease: a model system or system of models?

Authors:  Salim I Khakoo; Mary Carrington
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

Review 4.  Keeping NK cells in highly regulated antiviral warfare.

Authors:  Seung-Hwan Lee; Takuya Miyagi; Christine A Biron
Journal:  Trends Immunol       Date:  2007-04-27       Impact factor: 16.687

Review 5.  Prospects for the use of NK cells in immunotherapy of human cancer.

Authors:  Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

6.  Human NK cell education by inhibitory receptors for MHC class I.

Authors:  Nicolas Anfossi; Pascale André; Sophie Guia; Christine S Falk; Sophie Roetynck; C Andrew Stewart; Violette Breso; Coralie Frassati; Denis Reviron; Derek Middleton; François Romagné; Sophie Ugolini; Eric Vivier
Journal:  Immunity       Date:  2006-08-10       Impact factor: 31.745

Review 7.  Activation, coactivation, and costimulation of resting human natural killer cells.

Authors:  Yenan T Bryceson; Michael E March; Hans-Gustaf Ljunggren; Eric O Long
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

8.  A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8.

Authors:  Celine Eidenschenk; Jean Dunne; Emmanuelle Jouanguy; Claire Fourlinnie; Laure Gineau; Delphine Bacq; Corrina McMahon; Owen Smith; Jean-Laurent Casanova; Laurent Abel; Conleth Feighery
Journal:  Am J Hum Genet       Date:  2006-02-17       Impact factor: 11.025

9.  Dendritic cells prime natural killer cells by trans-presenting interleukin 15.

Authors:  Mathias Lucas; William Schachterle; Karin Oberle; Peter Aichele; Andreas Diefenbach
Journal:  Immunity       Date:  2007-03-29       Impact factor: 31.745

10.  Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46.

Authors:  Thierry Walzer; Mathieu Bléry; Julie Chaix; Nicolas Fuseri; Lionel Chasson; Scott H Robbins; Sébastien Jaeger; Pascale André; Laurent Gauthier; Laurent Daniel; Karine Chemin; Yannis Morel; Marc Dalod; Jean Imbert; Michel Pierres; Alessandro Moretta; François Romagné; Eric Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

View more
  1018 in total

1.  IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques.

Authors:  H Xu; X Wang; D X Liu; T Moroney-Rasmussen; A A Lackner; R S Veazey
Journal:  Mucosal Immunol       Date:  2012-06-06       Impact factor: 7.313

2.  Natural killer cell engineering for cellular therapy of cancer.

Authors:  D R Shook; D Campana
Journal:  Tissue Antigens       Date:  2011-12

3.  Identification of the earliest natural killer cell-committed progenitor in murine bone marrow.

Authors:  John W Fathman; Deepta Bhattacharya; Matthew A Inlay; Jun Seita; Holger Karsunky; Irving L Weissman
Journal:  Blood       Date:  2011-09-19       Impact factor: 22.113

4.  Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapy.

Authors:  Caroline Veuillen; Thérèse Aurran-Schleinitz; Rémy Castellano; Jérôme Rey; Françoise Mallet; Florence Orlanducci; Laurent Pouyet; Sylvaine Just-Landi; Diane Coso; Vadim Ivanov; Xavier Carcopino; Réda Bouabdallah; Yves Collette; Cyril Fauriat; Daniel Olive
Journal:  J Clin Immunol       Date:  2012-02-09       Impact factor: 8.317

Review 5.  Natural killer cell tolerance: control by self or self-control?

Authors:  Baptiste N Jaeger; Eric Vivier
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

6.  A Daily Dose of 5 mg Folic Acid for 90 Days Is Associated with Increased Serum Unmetabolized Folic Acid and Reduced Natural Killer Cell Cytotoxicity in Healthy Brazilian Adults.

Authors:  Clovis Paniz; Juliano Felix Bertinato; Maylla Rodrigues Lucena; Eduardo De Carli; Patrícia Mendonça da Silva Amorim; Guilherme Wataru Gomes; Cecília Zanin Palchetti; Maria Stella Figueiredo; Christine M Pfeiffer; Zia Fazili; Ralph Green; Elvira Maria Guerra-Shinohara
Journal:  J Nutr       Date:  2017-07-19       Impact factor: 4.798

Review 7.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

8.  Generation and preclinical characterization of a Fc-optimized GITR-Ig fusion protein for induction of NK cell reactivity against leukemia.

Authors:  Benjamin Joachim Schmiedel; Antje Werner; Julia Steinbacher; Tina Nuebling; Corina Buechele; Ludger Grosse-Hovest; Helmut Rainer Salih
Journal:  Mol Ther       Date:  2013-02-05       Impact factor: 11.454

Review 9.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

10.  NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs.

Authors:  Vivien Béziat; Lisa L Liu; Jenny-Ann Malmberg; Martin A Ivarsson; Ebba Sohlberg; Andreas T Björklund; Christelle Retière; Eva Sverremark-Ekström; James Traherne; Per Ljungman; Marie Schaffer; David A Price; John Trowsdale; Jakob Michaëlsson; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.